▲ BUY
6
/ 10
Conviction
$ Value
$265K
Shares
20,000
Price
$13
Filed
Oct 20
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Hoerter Steven L.
Title
—
CIK
0001533451
Roles
Director
Transaction Details
Transaction Date
2025-10-17
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
20,000
Footnotes
Shares held by the Steven L Hoerter Revocable Trust dated November 2, 2018, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Filing Info
Hoerter Steven L.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | ORIC | A | $0 |
| 2025-11-22 | MBX | A | $0 |
| 2025-11-22 | MBX | A | $0 |
| 2025-11-06 | MBX | A | $0 |
| 2025-11-06 | MBX | A | $0 |
| 2025-10-17 | MBX | ▲ | $265K ★ |
| 2025-06-18 | CCCC | A | $0 |
| 2025-06-05 | MBX | A | $0 |
Other Insiders at MBX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hawryluk P. Kent
President & CEO
|
$526K | — | 2026-03-13 |
| Hoerter Steven L. | — | — | 2025-11-22 |
|
Bartram Richard
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Azoulay Salomon
Chief Medical Officer
|
— | — | 2026-02-02 |